MANCHESTER, England--(BUSINESS WIRE)--Pharmaceutical companies are gearing up for an increase in running late phase cancer vaccine trials following draft guidance issued by the FDA last week.
MANCHESTER, England--(BUSINESS WIRE)--Pharmaceutical companies are gearing up for an increase in running late phase cancer vaccine trials following draft guidance issued by the FDA last week.
